Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2002 1
2012 1
2013 1
2014 10
2015 11
2016 4
2017 1
2018 4
2019 2
2020 3
2021 3
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
Tasimelteon for the treatment of non-24-hour sleep-wake disorder.
Neubauer DN. Neubauer DN. Drugs Today (Barc). 2015 Jan;51(1):29-35. doi: 10.1358/dot.2015.51.1.2258364. Drugs Today (Barc). 2015. PMID: 25685859 Review.
Tasimelteon (Hetlioz), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be approved by the U.S. Food and Drug Administration (FDA) for the treatment of non-24-hour sleep-wake disorder (non- …
Tasimelteon (Hetlioz), a melatonin receptor agonist, is the first, and, at the time of the publication, the only drug to be approved by the …
Tasimelteon.
[No authors listed] [No authors listed] 2020 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. 2020 Aug 20. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. PMID: 31643948 Free Books & Documents. Review.
Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake disorder in blind individuals. Tasimelteon therapy is associated with a low rate of serum enzyme elevations, but has not been implicated …
Tasimelteon is a melatonin receptor agonist that is used for the treatment of non-24 hour sleep-wake d …
Tasimelteon: A Review in Non-24-Hour Sleep-Wake Disorder in Totally Blind Individuals.
Keating GM. Keating GM. CNS Drugs. 2016 May;30(5):461-8. doi: 10.1007/s40263-016-0330-y. CNS Drugs. 2016. PMID: 27003694 Review.
Tasimelteon (Hetlioz()) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) (free-running disorder). ...
Tasimelteon (Hetlioz()) is a dual melatonin receptor agonist indicated for the treatment of Non-24-Hour Sleep- …
Non-24-Hour Sleep-Wake Disorder Revisited - A Case Study.
Garbazza C, Bromundt V, Eckert A, Brunner DP, Meier F, Hackethal S, Cajochen C. Garbazza C, et al. Front Neurol. 2016 Feb 29;7:17. doi: 10.3389/fneur.2016.00017. eCollection 2016. Front Neurol. 2016. PMID: 26973592 Free PMC article.
Tasimelteon: a melatonin receptor agonist for non-24-hour sleep-wake disorder.
Johnsa JD, Neville MW. Johnsa JD, et al. Ann Pharmacother. 2014 Dec;48(12):1636-41. doi: 10.1177/1060028014550476. Epub 2014 Sep 9. Ann Pharmacother. 2014. PMID: 25204464 Review.
OBJECTIVE: To examine the efficacy of tasimelteon for the treatment of non-24-hour sleep-wake disorder using evidence from controlled clinical trials. ...
OBJECTIVE: To examine the efficacy of tasimelteon for the treatment of non-24-hour sleep-wake disorder …
Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials.
Lockley SW, Dressman MA, Licamele L, Xiao C, Fisher DM, Flynn-Evans EE, Hull JT, Torres R, Lavedan C, Polymeropoulos MH. Lockley SW, et al. Lancet. 2015 Oct 31;386(10005):1754-64. doi: 10.1016/S0140-6736(15)60031-9. Epub 2015 Aug 4. Lancet. 2015. PMID: 26466871 Clinical Trial.
BACKGROUND: Most totally blind people have non-24-hour sleep-wake disorder (non-24), a rare circadian rhythm disorder caused by an inability of light to reset their circadian pacemaker. ...
BACKGROUND: Most totally blind people have non-24-hour sleep-wake disorder (non-24), a rare circad …
Diagnostic and Treatment Challenges of Sighted Non-24-Hour Sleep-Wake Disorder.
Malkani RG, Abbott SM, Reid KJ, Zee PC. Malkani RG, et al. J Clin Sleep Med. 2018 Apr 15;14(4):603-613. doi: 10.5664/jcsm.7054. J Clin Sleep Med. 2018. PMID: 29609703 Free PMC article.
STUDY OBJECTIVES: To report the diagnostic and treatment challenges of sighted non-24-hour sleep-wake disorder (N24SWD). METHODS: We report a series of seven sighted patients with N24SWD clinically evaluated by history and sleep diaries, …
STUDY OBJECTIVES: To report the diagnostic and treatment challenges of sighted non-24-hour sleep-wake …
40 results